Leap Therapeutics, Inc. (LPTX): Price and Financial Metrics


Leap Therapeutics, Inc. (LPTX): $2.08

0.04 (+1.96%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add LPTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 488

in industry

LPTX Stock Summary

  • For LPTX, its debt to operating expenses ratio is greater than that reported by merely 4.7% of US equities we're observing.
  • LPTX's price/sales ratio is 108.18; that's higher than the P/S ratio of 96.75% of US stocks.
  • As for revenue growth, note that LPTX's revenue has grown 200% over the past 12 months; that beats the revenue growth of 96.81% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Leap Therapeutics Inc, a group of peers worth examining would be GSIT, EDIT, XFOR, ARCT, and FPRX.
  • LPTX's SEC filings can be seen here. And to visit Leap Therapeutics Inc's official web site, go to www.leaptx.com.

LPTX Stock Price Chart Interactive Chart >

Price chart for LPTX

LPTX Price/Volume Stats

Current price $2.08 52-week high $3.24
Prev. close $2.04 52-week low $1.15
Day low $1.90 Volume 634,658
Day high $2.17 Avg. volume 858,755
50-day MA $2.42 Dividend yield N/A
200-day MA $2.09 Market Cap 124.09M

Leap Therapeutics, Inc. (LPTX) Company Bio


Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in acquiring and developing therapeutics in cancer biology. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was founded in 2011 and is based in Cambridge, Massachusetts.


LPTX Latest News Stream


Event/Time News Detail
Loading, please wait...

LPTX Latest Social Stream


Loading social stream, please wait...

View Full LPTX Social Stream

Latest LPTX News From Around the Web

Below are the latest news stories about Leap Therapeutics Inc that investors may wish to consider to help them evaluate LPTX as an investment opportunity.

Leap Therapeutics to Present at Upcoming Virtual Investor Conferences

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at the following virtual investor conferences:

Yahoo | February 22, 2021

The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11) 10X Genomics Inc (NASDAQ: TXG ) 9 Meters Biopharma Inc (NASDAQ: NMTR ) Abbott Laboratories (NYSE: ABT ) Acasti Pharma Inc (NASDAQ: ACST ) (reacted to its quarterly results) Advaxis, Inc. (NASDAQ: ADXS ) Agios Pharmaceuticals Inc (NASDAQ: AGIO ) Alimera Sciences Inc (NASDAQ: ALIM ) Alkermes Plc (NASDAQ: ALKS ) Allakos Inc (NASDAQ: ALLK ) Anchiano Therapeutics Ltd – ADR (NASDAQ: ANCN AngioDynamics, Inc. (NASDAQ: ANGO ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) Apyx Medical Corp (NASDAQ: APYX ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Artelo Biosciences Inc (NASDAQ: ARTL ) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) AtriCure Inc. (NASD...

Benzinga | February 11, 2021

Leap Therapeutics to Present at H.C. Wainwright BioConnect 2021 Conference

CAMBRIDGE, Mass., Jan. 6, 2021 /PRNewswire/ -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at…

PR Newswire | January 6, 2021

Leap Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference

Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at the 39th Annual J.P. Morgan Healthcare Conference. The conference will be held in a virtual meeting format.

Yahoo | January 4, 2021

Is LPTX A Good Stock To Buy Now?

In this article you are going to find out whether hedge funds think LEAP THERAPEUTICS, INC. (NASDAQ:LPTX) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks […]

Yahoo | December 12, 2020

Read More 'LPTX' Stories Here

LPTX Price Returns

1-mo -14.05%
3-mo 25.30%
6-mo 12.43%
1-year -20.00%
3-year -67.80%
5-year N/A
YTD -7.56%
2020 100.89%
2019 -44.00%
2018 -67.95%
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.0843 seconds.